These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7694266

  • 41. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
    Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T.
    J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
    [Abstract] [Full Text] [Related]

  • 42. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells.
    Damassa DA, Lin TM, Sonnenschein C, Soto AM.
    Endocrinology; 1991 Jul; 129(1):75-84. PubMed ID: 2055206
    [Abstract] [Full Text] [Related]

  • 43. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 44. ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002.
    Tørring N, Dagnaes-Hansen F, Sørensen BS, Nexø E, Hynes NE.
    Prostate; 2003 Jul 01; 56(2):142-9. PubMed ID: 12746839
    [Abstract] [Full Text] [Related]

  • 45. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
    Olea N, Sakabe K, Soto AM, Sonnenschein C.
    Endocrinology; 1990 Mar 01; 126(3):1457-63. PubMed ID: 2307113
    [Abstract] [Full Text] [Related]

  • 46. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
    Lyng FM, Jones GR, Rommerts FF.
    Biol Reprod; 2000 Sep 01; 63(3):736-47. PubMed ID: 10952915
    [Abstract] [Full Text] [Related]

  • 47. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines].
    Kellner U, Wagner B, Otto U, Voigt KD, Dietel M, Knabbe C.
    Verh Dtsch Ges Pathol; 1993 Sep 01; 77():124-8. PubMed ID: 7511269
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
    Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH.
    J Androl; 2008 Sep 01; 29(6):661-8. PubMed ID: 18676361
    [Abstract] [Full Text] [Related]

  • 50. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.
    Cancer Res; 2004 Aug 01; 64(15):5489-95. PubMed ID: 15289359
    [Abstract] [Full Text] [Related]

  • 51. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
    Schatten H, Ripple M, Balczon R, Weindruch R, Chakrabarti A, Taylor M, Hueser CN.
    J Cell Biochem; 2000 Jan 01; 76(3):463-77. PubMed ID: 10649443
    [Abstract] [Full Text] [Related]

  • 52. Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine.
    Pinto JT, Qiao C, Xing J, Suffoletto BP, Schubert KB, Rivlin RS, Huryk RF, Bacich DJ, Heston WD.
    Prostate; 2000 Dec 01; 45(4):304-14. PubMed ID: 11102955
    [Abstract] [Full Text] [Related]

  • 53. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM.
    Cancer Res; 2000 Dec 01; 60(23):6630-40. PubMed ID: 11118046
    [Abstract] [Full Text] [Related]

  • 54. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
    Fujii Y, Kawakami S, Okada Y, Kageyama Y, Kihara K.
    Am J Physiol Endocrinol Metab; 2004 Jun 01; 286(6):E927-31. PubMed ID: 14761877
    [Abstract] [Full Text] [Related]

  • 55. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW, Lau KW, Tam PC, Shiu SY.
    Prostate; 2002 Jul 01; 52(2):106-22. PubMed ID: 12111702
    [Abstract] [Full Text] [Related]

  • 56. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, Miyamoto M.
    Cancer Res; 2003 Jan 01; 63(1):149-53. PubMed ID: 12517791
    [Abstract] [Full Text] [Related]

  • 57. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.
    Veldscholte J, Voorhorst-Ogink MM, Bolt-de Vries J, van Rooij HC, Trapman J, Mulder E.
    Biochim Biophys Acta; 1990 Apr 09; 1052(1):187-94. PubMed ID: 2322591
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
    Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ.
    Oncogene; 2004 Mar 18; 23(12):2197-205. PubMed ID: 14767470
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.